Skip to content
Open access

Prognostic value of the nutritional risk index and prognostic nutritional index for immunotherapy outcomes in cervical Cancer

Aug 2026 · Gynecologic Oncology Reports · Vol 67, pp. 102184 · 0 citations · 51 references
Medicine

TL;DR

In this cohort of CC patients treated with IO, approximately 39% and 55% of patients were categorized as high risk according to pre-treatment NRI and PNI, respectively, and high-risk PNI and NRI classifications were associated with differences in irAEs, IO response, and oncologic outcomes.

Abstract

Objective(s): To evaluate the association of the Prognostic Nutritional Index (PNI) and Nutritional Risk Index (NRI) with immune-related adverse events, immunotherapy response, and oncologic outcomes. Methods: This study is an IRB-approved retrospective, single-institution cohort study in patients with CC treated with IO from January 1, 2017 to January 1, 2023. Clinical, oncologic, and nutritional parameters were collected from patient charts. The NRI and the PNI are validated composite prognostic indices derived from routinely collected laboratory and anthropometric parameters to evaluate nutritional status. Factors associated with NRI and PNI were evaluated. Progression-free survival (PFS) was defined from the start date of IO until progression of disease, and overall survival (OS) from time of diagnosis to death, with censoring at last follow-up. Kaplan Meier methods were used to assess survival outcomes. Results: 71 patients with CC were treated with IO during the study period. 61% (n = 43) of patients met criteria for low-risk NRI prior to receiving IO, with the remaining 39% (n = 27) meeting criteria for high-risk NRI. Low-risk NRI scores were associated with lower ECOG scores, increased grade 3/4 immune-related adverse events (G3/4 irAEs), and an improvement in OS, p < 0.05. Low-risk post-IO NRI scores were associated with a significant improvement in PFS and OS, p < 0.05. High-risk PNI scores were associated with higher ECOG scores, fewer G3/4 irAEs, and increased hospitalizations during IO, p < 0.05. Low-risk PNI scores were associated with improved response to IO as well as prolonged PFS and OS, p < 0.05. Conclusion(s): In this cohort of CC patients treated with IO, approximately 39% and 55% of patients were categorized as high risk according to pre-treatment NRI and PNI, respectively. High-risk PNI and NRI classifications were associated with differences in irAEs, IO response, and oncologic outcomes.

Read PDF

Similar papers

Open access Sep 2026

Prognostic Value of the Prognostic Nutritional Index in Patients with Metastatic Melanoma

Background Prognostic outcomes vary considerably among patients with metastatic melanoma. We examined the association of the prognostic nutritional index (PNI), neutrophil-to-lymphocyte ratio (NLR), and systemic immune-inflammation index (SII) with overall survival in this patient population. Methods We retrospectively...

M. Şahbazlar, Hikmet Akar, A. Erdoğan et al. · 0 citations
Open access Sep 2026

Prognostic Nutritional Index Is Associated With Gastrointestinal Symptom Severity in Patients Receiving Chemotherapy for Gastrointestinal Cancer: A Cross-Sectional Study.

OBJECTIVE This study aimed to investigate the relationship between the Prognostic Nutritional Index (PNI) and chemotherapy-related gastrointestinal (GI) symptom severity in patients with GI cancer. METHODS This observational cross-sectional study included 262 adult patients with GI cancer receiving chemotherapy at a...

Yasemin Çıracı Yaşar, Mehtap Tan, M. Bilici et al. · 0 citations
Open access Aug 2026

Pretreatment Geriatric Nutritional Risk Index in RADPLAT-treated Patients With Oral Squamous Cell Carcinoma: A Pilot Study

Background/Aim: Pretreatment nutritional and inflammatory indices have been associated with prognosis in patients with oral squamous cell carcinoma (OSCC) undergoing surgery or chemoradiotherapy; however, their prognostic significance in patients treated with superselective intra-arterial infusion of cisplatin and conc...

Akemi Ohtani, Masato Saito, Tomokazu Hasegawa et al. · 0 citations
Open access Aug 2026

Prognostic nutritional index in evaluating the prognosis of ICIs in patients with advanced esophageal squamous carcinoma

Objective This study aimed to investigate the association between the Prognostic Nutritional Index (PNI) and the prognosis of advanced esophageal squamous cell carcinoma (ESCC) patients treated with immune checkpoint inhibitors (ICIs). Methods We retrospectively analyzed the clinical data of 157 advanced ESCC patients...

Q. Shi, Man Li, Da-Qing Wang et al. · 0 citations
Open access Sep 2026

Baseline Inflammatory and Nutritional Indices Show Limited Discrimination for Major Pathological Response and Survival After Neoadjuvant Chemotherapy for Gastric Cancer: A Retrospective Comparison of Eleven Indices

Background/Objectives: While perioperative chemotherapy is standard for locally advanced gastric cancer, no baseline blood marker reliably identifies which patients will respond to treatment. In this retrospective study, we compared eleven inflammatory and nutritional indices against pathological response and survival...

Erkut Demirciler, K. Canaslan, H. I. Ellez et al. · 0 citations
Review Open access Sep 2026

Prognostic value of the prognostic nutritional index in sepsis, pneumonia, and tuberculosis: a systematic review and meta-analysis

Objective To evaluate the prognostic value of the Prognostic Nutritional Index (PNI) in patients with infectious diseases, focusing on tuberculosis, pneumonia, and sepsis. By synthesizing extant evidence, we examine the association between baseline PNI and clinical outcomes to inform early risk stratification and nutri...

Zhi-Heng Fu, Wan-Peng Wang · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.